McRae Capital Management’s Xylem XYL Stock Holding History

McRae Capital Management’s Portfolio XYL Stock Details XYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$334K	Sell	2,826 -749	-21%	-$86.5K	0.07%	87
2026 Q1	$427K	Hold	3,575	–	–	0.09%	78
2025 Q4	$487K	Hold	3,575	–	–	0.1%	67
2025 Q3	$527K	Hold	3,575	–	–	0.1%	70
2025 Q2	$463K	Hold	3,575	–	–	0.09%	73
2025 Q1	$427K	Hold	3,575	–	–	0.09%	69
2024 Q4	$415K	Buy	3,575 +100	+3%	+$12.6K	0.08%	71
2024 Q3	$469K	Hold	3,475	–	–	0.09%	66
2024 Q2	$471K	Buy	3,475 +1	+0%	+$136	0.11%	65
2024 Q1	$449K	Buy	3,474 +3	+0.1%	+$362	0.1%	70
2023 Q4	$397K	Buy	3,471 +4	+0.1%	+$399	0.1%	70
2023 Q3	$316K	Buy	3,467 +5	+0.1%	+$516	0.09%	76
2023 Q2	$390K	Buy	3,462 +4	+0.1%	+$423	0.11%	67
2023 Q1	$362K	Buy	3,458 +5	+0.1%	+$522	0.1%	74
2022 Q4	$382K	Sell	3,453 -197	-5%	-$20.6K	0.11%	72
2022 Q3	$319K	Buy	3,650 +5	+0.1%	+$454	0.1%	78
2022 Q2	$285K	Sell	3,645 -370	-9%	-$30.6K	0.08%	85
2022 Q1	$342K	Buy	4,015 +5	+0.1%	+$479	0.08%	84
2021 Q4	$481K	Buy	4,010 +3	+0.1%	+$372	0.1%	70
2021 Q3	$496K	Sell	4,007 -97	-2%	-$12.5K	0.11%	67
2021 Q2	$492K	Buy	4,104 +3	+0.1%	+$343	0.11%	65
2021 Q1	$431K	Sell	4,101 -66	-2%	-$6.69K	0.11%	67
2020 Q4	$424K	Sell	4,167 -496	-11%	-$46.6K	0.12%	64
2020 Q3	$392K	Sell	4,663 -369	-7%	-$28.7K	0.13%	65
2020 Q2	$327K	Buy	5,032 +7	+0.1%	+$462	0.12%	69
2020 Q1	$327K	Buy	5,025 +8	+0.2%	+$630	0.16%	65
2019 Q4	$395K	Buy	5,017 +5	+0.1%	+$389	0.15%	67
2019 Q3	$399K	Buy	5,012 +6	+0.1%	+$471	0.16%	64
2019 Q2	$419K	Buy	5,006 +5	+0.1%	+$398	0.17%	63
2019 Q1	$395K	Buy	5,001 +5	+0.1%	+$365	0.16%	66
2018 Q4	$333K	Sell	4,996 -244	-5%	-$16.9K	0.17%	66
2018 Q3	$419K	Sell	5,240 -109	-2%	-$8.14K	0.18%	63
2018 Q2	$360K	Sell	5,349 -291	-5%	-$21.1K	0.15%	74
2018 Q1	$434K	Sell	5,640 -500	-8%	-$37K	0.2%	58
2017 Q4	$419K	Hold	6,140	–	–	0.18%	62
2017 Q3	$385K	Sell	6,140 -110	-2%	-$6.57K	0.17%	63
2017 Q2	$346K	Sell	6,250 -500	-7%	-$26K	0.14%	72
2017 Q1	$339K	Sell	6,750 -1,000	-13%	-$48.7K	0.14%	72
2016 Q4	$384K	Sell	7,750 -500	-6%	-$25.3K	0.17%	64
2016 Q3	$433K	Hold	8,250	–	–	0.2%	61
2016 Q2	$368K	Buy	8,250 +1,250	+18%	+$54.3K	0.17%	66
2016 Q1	$286K	Buy	+7,000	New	+$258K	0.13%	78

Other funds holding XYL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

McRae Capital Management's XYL Position: Q2 2026 in Review

McRae Capital Management reduced its Xylem (XYL) stake by 21% in Q2 2026, selling an estimated $86.5K and leaving 2,826 shares worth $334K. The position accounts for 0.07% of the portfolio, ranked #87.

McRae Capital Management first reported a position in XYL in Q1 2016 and has held it in 42 quarters since. The position peaked at $527K in Q3 2025. 1,092 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

McRae Capital Management held 2,826 shares of Xylem worth $334K as of Q2 2026.
McRae Capital Management sold 749 Xylem shares in Q2 2026, an estimated $86.5K.
Xylem made up 0.07% of McRae Capital Management's portfolio in Q2 2026, its #87 holding.
McRae Capital Management first reported a position in Xylem in Q1 2016 and has held it in 42 quarters since.
McRae Capital Management's Xylem position peaked at $527K in Q3 2025.
1,092 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on McRae Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.